Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Express Scripts Holding Co

ESRX

Express Scripts Holding Co

Express Scripts Holding Co historical holders

total: 15

ValueAct Holdings Express Scripts Holding Co transactions over time

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2017 Q4
Held for:
1 quarter
Latest activity:
2018 Q1
Jeffrey Ubben has been an institutional investor in Express Scripts Holding Co (ESRX) since 2017 Q4. According to 2026 Q1 report, Jeffrey Ubben doesn't hold any shares. The fund/company first acquired ESRX in 2017 Q4, initially purchasing about 1.20M shares. Since the initial investment, ValueAct Holdings has made 1 more transaction in this position.

When did Jeffrey Ubben exit their ESRX position?

Jeffrey Ubben no longer holds Express Scripts Holding Co (ESRX). They sold off their entire position in 2018 Q1, closing out an investment that began in 2017 Q4.

When did Jeffrey Ubben first invest in ESRX?

Jeffrey Ubben first invested in Express Scripts Holding Co (ESRX) in 2017 Q4 at the reported quarter-end price of $74.64 per share, acquiring 1,200,000 shares in their initial purchase.

What is Jeffrey Ubben's average cost basis for ESRX?

Based on historical transaction data, Jeffrey Ubben's estimated cost basis for Express Scripts Holding Co (ESRX) is approximately $74.64 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$74.64
Weighted AVG sell price:
$74.64

ESRX transactions history by ValueAct Holdings

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2018 Q1
0.00%
$74.64
-100% (-1,200,000)
2017 Q4
0.91%
$74.64
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.